Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Type 2 Diabetes Mellitus Age: Adults |
Dose: Tablet – 10 mg/5 mg Frequency: once daily in the morning Note: Indicated as an adjunct to diet and exercise to improve glycemic control when both empagliflozin and linagliptin are appropriate treatments. Hepatic impairment: No dose adjustment required |
|
Indication: Type 2 Diabetes Mellitus Age: Adults Condition: If needed and tolerated |
Dose: Tablet – 25 mg/5 mg Frequency: once daily Note: Dose may be increased to this level. Hepatic impairment: No dose adjustment required |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment eGFR greater than 45 mL/min/1.73 m2 |
Dose: Not specified Note: No dose adjustment required |
|
Condition: Renal impairment eGFR 30-45 mL/min/1.73 m2 |
Dose: Not specified Note: Do not initiate drug. Discontinued if eGFR is persistently drops to less than 45 mL/min/1.73 m2 |
Administration
- May be taken with or without food
- Take at same time each day
Side Effect
- Urinary Tract Infection (UTI) (11.4-12.5%)
- Upper respiratory tract infection (URTI) (7%)
- Nasopharyngitis (5.9-6.6%)
- Increased LDL-C (4.6-6.5%)
- Hypoglycemia (2.2-3.6%)
- Increased hematocrit (2.8%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Insulin, sulphonylureas
|
May increase risk of hypoglycemia
|
|
UGT enzyme inducers
|
Risk of decreased efficacy
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.